Baxten Healthcare Pvt. Ltd., based in Mumbai, is a specialty
pharmaceutical company that manufactures and distributes a diverse
portfolio of healthcare products. These include intravenous infusions,
ophthalmic solutions, sterilized water for injections, nebules, tablets,
capsules, ointments, and creams.
Founded in 2001, our mission is to provide high-quality large and small
volume parenterals at the most economical prices. We recognized the need
for a leading pharmaceutical organization dedicated to producing assured
quality products in this field.
Baxten boasts the largest production capacity for intravenous infusions
in India. With the acquisition of Baxter International's FFS Division,
our presence in both domestic and global markets has strengthened
significantly.
To serve our domestic and international clients, we have strategically
located manufacturing plants in Roorkee (North), Waluj (West), and
Alathur (South).
Each year, our team connects with approximately 12,000 hospitals and
nursing homes. We are expanding our capacities at all three locations to
enhance our footprint in the Indian market and increase exports.
Our company has achieved significant quality certifications, including
WHO-GMP, ISO 9001:2015, and PIC/S, marking our adherence to
international standards. We have obtained certifications for various
countries such as Ukraine, Kenya, the Philippines, Ivory Coast, Nepal,
Nigeria, Uganda, and Kazakhstan, with more in progress.
year 2001
Inception of Baxten Healthcare i.e started
marketing with pharmaceutical products
year 2003
Awarded One Star Export House status by the Government of India
year 2007
Started commercial production of Intravenous Infusions at Roorkee
year 2008
Received WHO – GMP certification and started exports to over 15 markets
worldwide
year 2010
Awarded the Top Exporter Award for Medium Scale Enterprises by
Chemexcil. Acquired the second unit in Roorkee for manufacturing oral
dosage formulations
year 2014
Baxter USA, Global Audit Approval, and Approval from PICs
year 2016
OrbiMed investment into the Company. Agreement to acquire Baxter India’s
IV business. Certification from ISO 9001:2015